DE69902766D1 - N-aryloxyethylaminderivate zur behandlung der depression - Google Patents

N-aryloxyethylaminderivate zur behandlung der depression

Info

Publication number
DE69902766D1
DE69902766D1 DE69902766T DE69902766T DE69902766D1 DE 69902766 D1 DE69902766 D1 DE 69902766D1 DE 69902766 T DE69902766 T DE 69902766T DE 69902766 T DE69902766 T DE 69902766T DE 69902766 D1 DE69902766 D1 DE 69902766D1
Authority
DE
Germany
Prior art keywords
hydrogen
halogen
lower alkyl
alkoxy
treating depression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69902766T
Other languages
English (en)
Other versions
DE69902766T2 (de
Inventor
Eric Mewshaw
Dahui Zhou
Ping Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of DE69902766D1 publication Critical patent/DE69902766D1/de
Application granted granted Critical
Publication of DE69902766T2 publication Critical patent/DE69902766T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69902766T 1998-04-08 1999-04-07 N-aryloxyethylaminderivate zur behandlung der depression Expired - Fee Related DE69902766T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5730798A 1998-04-08 1998-04-08
PCT/US1999/007622 WO1999051576A1 (en) 1998-04-08 1999-04-07 N-aryloxyethylamine derivatives for the treatment of depression

Publications (2)

Publication Number Publication Date
DE69902766D1 true DE69902766D1 (de) 2002-10-10
DE69902766T2 DE69902766T2 (de) 2003-02-06

Family

ID=22009801

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69902766T Expired - Fee Related DE69902766T2 (de) 1998-04-08 1999-04-07 N-aryloxyethylaminderivate zur behandlung der depression

Country Status (11)

Country Link
EP (1) EP1068184B1 (de)
JP (1) JP2002510676A (de)
CN (1) CN1160332C (de)
AT (1) ATE223379T1 (de)
AU (1) AU3386299A (de)
CA (1) CA2327303A1 (de)
DE (1) DE69902766T2 (de)
DK (1) DK1068184T3 (de)
ES (1) ES2182509T3 (de)
PT (1) PT1068184E (de)
WO (1) WO1999051576A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0015401A (pt) * 1999-11-08 2002-07-02 Wyeth Corp [(indol-3-il)-cicloalquil]-3-azetidinas substituìdas para o tratamento de distúrbios do sistema nervoso central
DE10006139A1 (de) * 2000-02-11 2001-08-16 Merck Patent Gmbh Indol-3-yl-Derivate
MXPA03008807A (es) 2001-03-29 2004-02-12 Bristol Myers Squibb Co Derivados de ciclopropilindol como inhibidores selectivos de recaptacion de serotonina.
US7041697B2 (en) * 2002-09-12 2006-05-09 Wyeth Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan
DE10305739A1 (de) * 2003-02-11 2004-08-19 Merck Patent Gmbh Benzofuranderivate
DE10306941A1 (de) * 2003-02-18 2004-08-26 Merck Patent Gmbh Benzofuranoxyethylamine
DE102006033109A1 (de) * 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
WO2009128088A2 (en) * 2008-04-15 2009-10-22 Shodhana Laboratories Limited Preparation of 2-(2-alkoxy phenoxy) ethylamine, an intermediate of carvedilol and tamsulosin
CN112358450A (zh) * 2020-11-19 2021-02-12 南京艾康生物科技有限公司 一种4-(苄氧基)-2-甲基-1H-苯并[d]咪唑-6-羧酸的合成方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468882A (en) * 1966-10-07 1969-09-23 Sterling Drug Inc Phenylhydrazone derivatives as intermediates for preparing indoles
US3371098A (en) * 1966-11-29 1968-02-27 Philips Corp 5- and 6-methoxy-3-(phenoxyethyl-aminoethyl)-indoles
DE2827874A1 (de) * 1978-06-24 1980-02-07 Merck Patent Gmbh Indolalkylamine und verfahren zu ihrer herstellung
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
US5124332A (en) * 1991-01-28 1992-06-23 Warner-Lambert Company Substituted indoles as central nervous system agents
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
JPH05125024A (ja) * 1991-11-05 1993-05-21 Yamanouchi Pharmaceut Co Ltd 新規なアリールオキシアルキルアミン誘導体又はその塩
US5314896A (en) * 1991-11-20 1994-05-24 Warner-Lambert Company 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
JPH05255302A (ja) * 1992-03-09 1993-10-05 Yamanouchi Pharmaceut Co Ltd 新規なクロマニルオキシアルキルアミン誘導体
IT1271352B (it) * 1993-04-08 1997-05-27 Boehringer Ingelheim Italia Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
US5436264A (en) * 1993-08-19 1995-07-25 Syntex (U.S.A.) Inc. N-aryloxyalkyl tryptamine α1 -adrenergic receptor antagonists
US5468767A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
JPH0940648A (ja) * 1995-08-02 1997-02-10 Yamanouchi Pharmaceut Co Ltd 新規な８−（２−アミノアルコキシ）キノリン誘導体
PT923551E (pt) * 1996-08-27 2002-09-30 American Home Prod Derivados de 4-aminoetoxi indolona
EP0923548B1 (de) * 1996-08-27 2003-03-12 Wyeth 4-aminoethoxy-indolderivate als dopamin d2 agonisten und als 5ht1a liganden

Also Published As

Publication number Publication date
PT1068184E (pt) 2002-12-31
CN1160332C (zh) 2004-08-04
EP1068184A1 (de) 2001-01-17
WO1999051576A1 (en) 1999-10-14
ATE223379T1 (de) 2002-09-15
DK1068184T3 (da) 2002-12-30
ES2182509T3 (es) 2003-03-01
CA2327303A1 (en) 1999-10-14
JP2002510676A (ja) 2002-04-09
CN1303373A (zh) 2001-07-11
DE69902766T2 (de) 2003-02-06
AU3386299A (en) 1999-10-25
EP1068184B1 (de) 2002-09-04

Similar Documents

Publication Publication Date Title
DE60107435D1 (de) 2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission
HUP9904361A2 (hu) Izobutil-gaba és származékai alkalmazása fájdalom kezelésére
DE59600105D1 (de) Verwendung von Adamantan-Derivaten zur Behandlung von Tinnitus
DE69902766T2 (de) N-aryloxyethylaminderivate zur behandlung der depression
DE69321609D1 (de) Piperazinderivate
FI923540A (fi) Arylalkylaminer och -amider med antikonvulsiva och nervskyddande egenskaper.
DE69824476D1 (de) Alkylene-Derivat, Anti-ulcus und antibakterielle Arzneimittel
DE69406678D1 (de) Heterozyclische amine mit zns-wirksamkeit
DK0783495T3 (da) Quinoxalinderivater, der er egnede i terapi
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
CO5040091A1 (es) Derivados de urea
PT1049672E (pt) Derivados de azetidinocarboxamida para o tratamento de disturbios do snc
NO994343L (no) Anvendelse av 2,3,4,5 - tetrahydro- 1H-3-benzazepiner for fremstilling av en farmasöytisk blanding for behandlingen av soveuregelmessigheter
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
DE60000405T2 (de) 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression
DE69903930D1 (de) N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen
DE69902142T2 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
ATE200673T1 (de) 1,9-diazabicyclo(4.3.0)nona-3,8-dienderivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee